pegylated


Also found in: Medical, Wikipedia.
Translations

pegylated

adj pegilado
Mentioned in ?
References in periodicals archive ?
The patients were clinically evaluated to determine whether they were candidates for treatment with pegylated interferon a-2a or a-2b plus ribavirin.
M2 EQUITYBITES-July 28, 2017-Eiger wins US FDA's fast track designation for pegylated interferon lambda for the treatment of hepatitis delta virus infection
M2 PHARMA-July 28, 2017-Eiger wins US FDA's fast track designation for pegylated interferon lambda for the treatment of hepatitis delta virus infection
Contract awarded for 677-2016 list pegylated interferon alfa-2b vial or prefilled syringe 50 mcg - 180 mcg code 2065
In this research, liposome nanocarriers and pegylated liposome have been produced through reverse phase vaporization process.
1) The sustained virological response (RVS) rate to combination treatment with pegylated interferon and ribavirin for HCV genotype 1 ranges from 30 to 50%.
ST), a research-based pharmaceutical company focused on infectious diseases, announced today the approval by the Russian Ministry of Health of Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection in combination with pegylated interferon and ribavirin in HCV genotype 1 and 4 infected patients with compensated liver disease, including cirrhosis.
Saleem Qureshi, Co-Investigator EUROP Trial from KRL Hospital Islamabad presented Getz Pharma's Clinical Trial findings titled "A Multicenter Evaluation of Pegylated Interferon (UNIPEG) FOR RESPONSE IN PAKISTANI POPULATION (EUROP)" at the conference which was well received by the audience & faculty at the ICVH 2013.
BOSTON - Adding pegylated interferon alfa-2a to entecavir increased the chance of long-term viral suppression of chronic hepatitis 13 infections in a randomized trial of 160 patients.
presented EUROP (Evaluation of Pegylated Interferon (Unipeg(r)) for Response in Pakistani Population) Clinical Trial Study at the conference, which was well received by the delegates and drew attention from luminaries in Hepatology.
A Food and Drug Administration advisory panel unanimously supported the approval of the oral antiviral drug telaprevir as a treatment for genotype 1 chronic hepatitis C when combined with pegylated interferon and ribavirin, the current standard of care.
Minister of Health Makhdoom Shahabuddin lauded the initiative taken by Getz Pharma to produce Pegylated Interferon locally as it is a service to those suffering from the Hepatitis C virus.